Akron Children's Logo
Skip to main content
Close Tools Menu Icon

Operator:

330-543-1000

Questions or Referrals:
ASK CHILDREN‘S

Close Phone Menu Icon
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Safety and efficacy of ASP0367 in patients with primary mitochondrial myopathy

Full IRB Study Title:
A Randomized, Double-blind, Placebo-controlled Adaptive Phase 2/3 Study with Open-label Extension to Assess the Efficacy, Safety and Tolerability of ASP0367 in Participants with Primary Mitochondrial Myopathy

IRB Study ID: 1713067

See complete study details here.

Study Sponsor:

Astellas Pharma, Inc.

 We are currently recruiting

If you are interested in this study or have questions about your child's eligibility, please contact:

Hilary Tonni, htonni@akronchildrens.org, 330-543-3193

Lead Investigator

Bruce H. Cohen

Bruce H. Cohen, MD, FAAN

Chair, NeuroDevelopmental Science Center; Philip H. Maynard Chair in NeuroDevelopmental Science Fund; Chairman, American Academy of Neurology Advocacy Committee; Pediatric Neurologist


Pediatric Brain Tumor ProgramPediatric NeurologyMitochondrial Center

More about this provider

Back to top of page

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.